Connor, Clark & Lunn Investment Management (CC&L)
RXRX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Recursion Pharmaceuticals RXRX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio RXRX Stock Details RXRX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-227,892
Closed -$1.52M – 1470
2023
Q1 		$1.52M Buy
227,892
+83,879
+58% +$559K 0.01% 622
2022
Q4 		$1.11M Buy
+144,013
New +$1.11M 0.01% 678